Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23963190 | 0.93 | CHRM2 (0.34) | ATM | |
| SCHEMBL68323 | 0.92 | ATM (0.30) | ATM | |
| SCHEMBL69388 | 0.92 | ATM (0.36) | ATMNPC1RAB9ANPSR1L3MBTL1 | |
| SCHEMBL12932699 | 0.92 | NPC1 (0.31) | ATMNPC1RAB9ANPSR1L3MBTL1 | |
| SCHEMBL23633736 | 0.90 | — | — | |
| SCHEMBL31380258 | 0.89 | — | — | |
| SCHEMBL23633734 | 0.89 | — | — | |
| SCHEMBL10306300 | 0.87 | — | — | |
| SCHEMBL10175857 | 0.87 | — | — | |
| SCHEMBL15356235 | 0.87 | NPC1 (0.39) | ATMNPC1RAB9ANPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584309-A1 | POLYCYCLIC-OLEFINIC POLYMERS CONTAINING ACRYLATE FUNCTIONALITY WITH ACRYLATE/MALEIMIDE CROSSLINKERS AS B-STAGEABLE COMPOSITIONS FOR LOW LOSS APPLICATIONS | Promerus, LLC (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054548-A1 | POLYCYCLIC-OLEFINIC POLYMERS CONTAINING ACRYLATE FUNCTIONALITY WITH ACRYLATE/MALEIMIDE CROSSLINKERS AS B-STAGEABLE COMPOSITIONS FOR LOW LOSS APPLICATIONS | PROMERUS, LLC (US) | 2024-03-14 | — | — | WO | disclosed |